| Code | 2211D | ||||||||||
| MA number | 44/0238/19-S | ||||||||||
| Product Form: | tbl 10x10 mg (blis.Al/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister Al/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 01.08.2019 |
| Validity: | 01.08.2024 |
| MA renewed: | Renewal application submitted |
| SPC: |
SPC_Everolimus Vipharm 10 mg tablety_03.2023.pdf
|
| PIL: |
PIL_Everolimus Vipharm 10 mg tablety_03.2023.pdf
|
| Safety feature | Yes |
| Data update: | 27.03.2023 |
